Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping - PubMed (original) (raw)

Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping

S Keidel et al. Mol Cell Biol. 1994 Jan.

Abstract

The pleiotropic effects of retinoic acid on cell differentiation and proliferation are mediated by two subfamilies of nuclear receptors, the retinoic acid receptors (RARs) and the retinoid X receptors (RXRs). Recently the synthetic retinoid Ro 41-5253 was identified as a selective RAR alpha antagonist. As demonstrated by gel retardation assays, Ro 41-5253 and two related new RAR alpha antagonists do not influence RAR alpha/RXR alpha heterodimerization and DNA binding. In a limited trypsin digestion assay, complexation of RAR alpha with retinoic acid or several other agonistic retinoids altered the degradation of the receptor such that a 30-kDa proteolytic fragment became resistant to proteolysis. This suggests a ligand-induced conformational change, which may be necessary for the interaction of the DNA-bound RAR alpha/RXR alpha heterodimer with other transcription factors. Our results demonstrate that antagonists compete with agonists for binding to RAR alpha and may induce a different structural alteration, suggested by the tryptic resistance of a shorter 25-kDa protein fragment in the digestion assay. This RAR alpha conformation seems to allow RAR alpha/RXR alpha binding to DNA but not the subsequent transactivation of target genes. Protease mapping with C-terminally truncated receptors revealed that the proposed conformational changes mainly occur in the DE regions of RAR alpha. Complexation of RAR beta, RAR gamma, and RXR alpha, as well as the vitamin D3 receptor, with their natural ligands resulted in a similar resistance of fragments to proteolytic digestion. This could mean that ligand-induced conformational changes are a general feature in the hormonal activation of vitamin D3 and retinoid receptors.

PubMed Disclaimer

Similar articles

• Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
  Defacque H, Sévilla C, Piquemal D, Rochette-Egly C, Marti J, Commes T. Defacque H, et al. Leukemia. 1997 Feb;11(2):221-7. doi: 10.1038/sj.leu.2400568. Leukemia. 1997. PMID: 9009084
• Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
  Kizaki M, Dawson MI, Heyman R, Elster E, Morosetti R, Pakkala S, Chen DL, Ueno H, Chao W, Morikawa M, Ikeda Y, Heber D, Pfahl M, Koeffler HP. Kizaki M, et al. Blood. 1996 Mar 1;87(5):1977-84. Blood. 1996. PMID: 8634447
• A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
  Vivat V, Zechel C, Wurtz JM, Bourguet W, Kagechika H, Umemiya H, Shudo K, Moras D, Gronemeyer H, Chambon P. Vivat V, et al. EMBO J. 1997 Sep 15;16(18):5697-709. doi: 10.1093/emboj/16.18.5697. EMBO J. 1997. PMID: 9312028 Free PMC article.
• [Genetic control of the development by retinoic acid].
  Mark M, Kastner P, Ghyselinck NB, Krezel W, Dupé V, Chambon P. Mark M, et al. C R Seances Soc Biol Fil. 1997;191(1):77-90. C R Seances Soc Biol Fil. 1997. PMID: 9181129 Review. French.
• Receptor-selective retinoid agonists and teratogenic activity.
  Willhite CC, Dawson MI, Reichert U. Willhite CC, et al. Drug Metab Rev. 1996 Feb-May;28(1-2):105-19. doi: 10.3109/03602539608993994. Drug Metab Rev. 1996. PMID: 8744592 Review.

Cited by

• The promoter context is a decisive factor in establishing selective responsiveness to nuclear class II receptors.
  Sanguedolce MV, Leblanc BP, Betz JL, Stunnenberg HG. Sanguedolce MV, et al. EMBO J. 1997 May 15;16(10):2861-73. doi: 10.1093/emboj/16.10.2861. EMBO J. 1997. PMID: 9184230 Free PMC article.
• Multiple mutations contribute to repression by the v-Erb A oncoprotein.
  Lee S, Privalsky ML. Lee S, et al. Oncogene. 2005 Oct 13;24(45):6737-52. doi: 10.1038/sj.onc.1208826. Oncogene. 2005. PMID: 16007162 Free PMC article.
• HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target.
  Martinelli E, Tharinger H, Frank I, Arthos J, Piatak M Jr, Lifson JD, Blanchard J, Gettie A, Robbiani M. Martinelli E, et al. PLoS Pathog. 2011 Jun;7(6):e1002109. doi: 10.1371/journal.ppat.1002109. Epub 2011 Jun 30. PLoS Pathog. 2011. PMID: 21738472 Free PMC article.
• Developmental origins of a novel gut morphology in frogs.
  Bloom S, Ledon-Rettig C, Infante C, Everly A, Hanken J, Nascone-Yoder N. Bloom S, et al. Evol Dev. 2013 May;15(3):213-23. doi: 10.1111/ede.12035. Evol Dev. 2013. PMID: 23607305 Free PMC article.
• The nuclear receptor superfamily: A structural perspective.
  Weikum ER, Liu X, Ortlund EA. Weikum ER, et al. Protein Sci. 2018 Nov;27(11):1876-1892. doi: 10.1002/pro.3496. Protein Sci. 2018. PMID: 30109749 Free PMC article. Review.

References

1. 1. Biochim Biophys Acta. 1980 Mar 12;605(1):33-91 - PubMed
2. 1. Development. 1993 May;118(1):267-82 - PubMed
3. 1. Nature. 1987 Dec 17-23;330(6149):624-9 - PubMed
4. 1. Nature. 1987 Dec 17-23;330(6149):667-70 - PubMed
5. 1. Science. 1988 May 13;240(4854):889-95 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Guide to Pharmacology

• Research Materials

  • NCI CPTC Antibody Characterization Program